Alecensa (alectinib) 150 mg hard capsules, 224 capsules — original (Roche) Lung Cancer Targeted Cancer Therapy. Delivery of medications from Europe and beyond within 4-5 days, with strict storage conditions and payment upon receipt. +380996042415, Viber, WhatsApp.
- EMC post
Delivery time
- 7-10 days
- Payment to Revolut card
Display
The medicinal drug Alekensa® is a monotherapy of indications as a first-line drug for the treatment of adult patients with ALK*-positive advanced non-lichen cell carcinoma of the leg.
Likarsky zasib Alekenza® yak monotherapy indications for the treatment of adult patients with ALK-positive advanced cancer of the leg, who were previously treated with crizotinib.
Method of congestion and dose
Treatment with Alekenza® should be carried out immediately under the supervision of a doctor, which is proof of the stagnation of anti-tumor medications.
Trace the validation test to confirm ALK-positive NDRL. ALK? positive NDRL status, insert before treatment with Alekenza®.
Dozuvannya
The recommended dose for Alekenza® is 600 mg (some 150 mg capsules) 2 times per dose (the usual dose is 1200 mg) per hour of administration.
The initial dose for patients with severely impaired liver function (Child-Pugh class C) should be 450 mg twice a day for up to an hour of residence. Ezhi (flat dose is 900 mg).
- Trade Name:Alescensa
- Chemical Name:Alecetinib
- Dosage:150 mg
- Quantity:224
- Form of Issue:Tab
- Manufacturer:Roche. Germany
